NIVELLA Trademark

Trademark Overview


On Tuesday, December 13, 2022, a trademark application was filed for NIVELLA with the United States Patent and Trademark Office. The USPTO has given the NIVELLA trademark a serial number of 97715905. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, May 20, 2024. This trademark is owned by Medytox Inc.. The NIVELLA trademark is filed in the Pharmaceutical Products category with the following description:

Chemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; vaccines; medicated lotions for skin, hair, sunburn, face, body; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain
nivella

General Information


Serial Number97715905
Word MarkNIVELLA
Filing DateTuesday, December 13, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, May 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesChemico-pharmaceutical preparations for treating glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; bacterial poisons; pharmacological preparations for skin care, namely, pharmaceutical preparations for skin care; pharmaceutical agents for epidermis; injectable dermal fillers; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for treating skin disorders; vaccines; medicated lotions for skin, hair, sunburn, face, body; pharmaceuticals containing botulinum toxin for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain; pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient for medical use for use in the treatment of glabellar lines, forehead wrinkles, lateral canthal line, prostate disorder, excessive eye blinking, and pelvic pain

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 16, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMedytox Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressChungcheongbuk-do 28126
KR

Trademark Events


Event DateEvent Description
Friday, December 16, 2022NEW APPLICATION ENTERED
Wednesday, December 28, 2022ASSIGNED TO EXAMINER
Wednesday, January 4, 2023NON-FINAL ACTION WRITTEN
Friday, December 16, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, January 4, 2023NON-FINAL ACTION E-MAILED
Wednesday, January 4, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 7, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 10, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 8, 2023SUSPENSION LETTER WRITTEN
Thursday, June 8, 2023LETTER OF SUSPENSION E-MAILED
Thursday, June 8, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 12, 2024SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, February 3, 2024SUSPENSION INQUIRY WRITTEN
Saturday, February 3, 2024INQUIRY TO SUSPENSION E-MAILED
Saturday, February 3, 2024NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, May 20, 2024ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, May 20, 2024ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Wednesday, May 10, 2023ASSIGNED TO LIE